TMG

Category
metabolite
Routes
Oral (PO)
Half-Life (t½)
PO: 2h
Formula
C5H11NO2
Molecular Weight
117.15 g/mol
PubChem CID
247
Aliases
Trimethylglycine, Betaine, Betaine anhydrous

Pharmacological Mechanism

Methyl donor to homocysteine via betaine-homocysteine methyltransferase (BHMT) — a B12-independent remethylation route parallel to methionine synthase. Complementary methyl donor for high-methylation-demand protocols (e.g., NMN → NAD⁺ → methylated nicotinamide). Also a renal osmolyte and a performance-enhancement ergogenic at ~2.5 g/d (mechanism uncertain — possibly via methyl support for creatine synthesis).

Half-Life & Elimination Curve (PO: 2h)

100%50%25%12.5%0%0h0×t½2h1×t½4h2×t½6h3×t½8h4×t½10h5×t½0×t½ (0h): 100% remaining (~9.77 mg/L)1×t½ (2h): 50% remaining (~4.89 mg/L)2×t½ (4h): 25% remaining (~2.44 mg/L)3×t½ (6h): 12.5% remaining (~1.22 mg/L)4×t½ (8h): 6.3% remaining (~0.611 mg/L)5×t½ (10h): 3.1% remaining (~0.305 mg/L)
Plasma (PO)t½ Decay (2h)
  • 0×t½0h100% (9.77 mg/L)
  • 1×t½2h50% (4.89 mg/L)
  • 2×t½4h25% (2.44 mg/L)
  • 3×t½6h12.5% (1.22 mg/L)
  • 4×t½8h6.3% (0.611 mg/L)
  • 5×t½10h3.1% (0.305 mg/L)
Elimination t½2h (PO)
Rate Constant (ke)0.347 h⁻¹
Time to Peak (Tmax)1.27h
Est. Peak (Cmax)9.77 mg/L
Clearance (CL)9.7 L/h
97% Washout (5×t½)10h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Top Dietary Sources

Chemical Structure & Identifiers

References